About the MMRC
Letter from the Founder
Mission Statement
Steering Committee
Project Review Committee
Board of Directors
Staff
Employment Opportunities
The MMRC Model
Member Institutions
Myeloma Tissue Bank
Myeloma Data Bank
About Multiple Myeloma
Definition
Causes & Incidence
Symptoms & Staging
Treatments
Projects
Pre-Clinical Studies
Clinical Trials
Newsroom
Press Releases
Multimedia
Abstracts
For Patients
Patient Brochure
Frequently Asked Questions
Participating Centers
MMRC Video
Support the Cause
Pre-Clinical Studies
Genomics Projects
Genomics Initiative
PRESS RELEASE
MMRC Genomics Initiative Selected for Two Presentations at American Society of Hematology (ASH) Annual Meeting
PRESS RELEASE
MMRF, MMRC Launch Multiple Myeloma Genomics Portal
PRESS RELEASE
Multiple Myeloma Research Consortium (MMRC) Launches Myeloma Genome Mapping Program
FGFR3 Target Validation
ABSTRACT
Diagnostic Evaluation of t[4;14] in Multiple Myeloma
Tissue Bank Accrual
ABSTRACT
A Local Versus Centralized Processing Comparison of Plasma Cell Isolation, Viability, and RNA Integrity
NEWS ARTICLE
Chronicle of Philanthropy: New Database Assists Myeloma Research
PRESS RELEASE
Multiple Myeloma Research Consortium Opens GLP-Quality Tissue Bank
Validation Projects
Pre-Clinical Monoclonal Antibodies Validation Study
PRESS RELEASE
The Multiple Myeloma Research Consortium (MMRC) Announces the Initiation of Phase I/II Study of Elotuzumab (Huluc63) Monoclonal Antibody in Combination with Velcade
Development of a Myeloma Cell Line Panel